Epitope mapping of monoclonal antibodies using synthetic oligosaccharides uncovers novel aspects of immune recognition of the Psl exopolysaccharide of Pseudomonas aeruginosa.

Item

http://www.wikidata.org/entity/Q38311099

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Epitope mapping of monoclonal ...... ide of Pseudomonas aeruginosa.

@en

type

Item

label

Epitope mapping of monoclonal ...... ide of Pseudomonas aeruginosa.

@en

prefLabel

Epitope mapping of monoclonal ...... ide of Pseudomonas aeruginosa.

@en

P1476

Epitope mapping of monoclonal ...... ride of Pseudomonas aeruginosa

@en

P2093

Antonio DiGiandomenico

http://www.w3.org/2001/XMLSchema#string

Huiqing Li

http://www.w3.org/2001/XMLSchema#string

Kai-For Mo

http://www.w3.org/2001/XMLSchema#string

Qun Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

Genetic and biochemical analyses of the Pseudomonas aeruginosa Psl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS production

Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening.

The common Cryptococcus neoformans glucuronoxylomannan M2 motif elicits non-protective antibodies.

Versatile set of orthogonal protecting groups for the preparation of highly branched oligosaccharides

Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization.

The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections.

New principles for glycoside-bond formation.

Carbohydrate vaccines: developing sweet solutions to sticky situations?

P304

17425-17431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CHEM.201302916

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Geert-Jan Boons

Charles Kendall Stover

P577

2013-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258702064

http://www.w3.org/2001/XMLSchema#string

P698

24248772

http://www.w3.org/2001/XMLSchema#string

P921

beta-D-Manp-(1->3)-beta-D-Manp-(1->3)-alpha-L-Rhap-(1->3)-beta-D-GlcpO[CH2]3NH2

alpha-D-Manp-(1->2)-beta-D-Manp-(1->3)-beta-D-Manp-(1->3)-alpha-L-Rhap-(1->3)-beta-D-GlcpO[CH2]3NH2

beta-D-Glcp-(1->3)-[alpha-D-Manp-(1->2)]-beta-D-Manp-(1->3)-beta-D-Manp-(1->3)-alpha-L-Rhap-(1->3)-beta-D-GlcpO[CH2]3NH2

alpha-D-Manp-(1->2)-[alpha-D-Manp-(1->2)-beta-D-Manp-(1->3)-beta-D-Manp-(1->3)-alpha-L-Rhap-(1->3)-beta-D-Glcp-(1->3)]-beta-D-Manp-(1->3)-beta-D-Manp-(1->3)-alpha-L-Rhap-(1->3)-beta-D-GlcpO[CH2]3NH2

beta-D-Manp-(1->3)-beta-D-Manp-(1->3)-alpha-L-Rhap-(1->3)-beta-D-Glcp

alpha-D-Manp-(1->2)-beta-D-Manp-(1->3)-beta-D-Manp-(1->3)-alpha-L-Rhap-(1->3)-beta-D-Glcp

beta-D-Glcp-(1->3)-[alpha-D-Manp-(1->2)]-beta-D-Manp-(1->3)-beta-D-Manp-(1->3)-alpha-L-Rhap-(1->3)-beta-D-Glcp

alpha-D-Manp-(1->2)-[alpha-D-Manp-(1->2)-beta-D-Manp-(1->3)-beta-D-Manp-(1->3)-alpha-L-Rhap-(1->3)-beta-D-Glcp-(1->3)]-beta-D-Manp-(1->3)-beta-D-Manp-(1->3)-alpha-L-Rhap-(1->3)-beta-D-Glcp

Pseudomonas aeruginosa

oligosaccharide